Recent advances in understanding and treating ARDS.

F1000Research

Volumn 5, Issue , 2016, Pages

  Baron, Rebecca M ^a   Levy, Bruce D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISATRACURIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUROMUSCULAR BLOCKING AGENT; OXYGEN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; CLINICAL EFFECTIVENESS; DEEP SEDATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LUNG EDEMA; MORTALITY; NONHUMAN; NONINVASIVE VENTILATION; OXYGEN THERAPY; OXYGENATION; PHARMACOLOGICAL BLOCKING; POSITIVE END EXPIRATORY PRESSURE; PRONE POSITION; REVIEW; RISK FACTOR; TIDAL VOLUME; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 85010892508     PISSN: None     EISSN: 20461402     Source Type: Journal    
DOI: 10.12688/F1000RESEARCH.7646.1     Document Type: Review

References (37)

1. Hager DN: Recent Advances in the Management of the Acute Respiratory Distress Syndrome. Clin Chest Med. 2015; 36(3): 481-496.
2. Bernard GR, Artigas A, Brigham KL, et al.: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149(3 Pt 1): 818-824.
3. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al.: Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23): 2526-2533.
4. Sweatt AJ, Levitt JE: Evolving epidemiology and definitions of the acute respiratory distress syndrome and early acute lung injury. Clin Chest Med. 2014; 35(4): 609-624.
5. Calfee CS, Ware LB, Glidden DV, et al.: Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med. 2011; 39(4): 711-717.
6. Nakahira K, Kyung SY, Rogers AJ, et al.: Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013; 10(12): e1001577; discussion e1001577.
7. Jabaudon M, Blondonnet R, Roszyk L, et al.: Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2015; 192(2): 191-199.
8. Ware LB, Calfee CS: Biomarkers of ARDS: what's new? Intensive Care Med. 2016; 42(5): 797-799.
9. Calfee CS, Delucchi K, Parsons PE, et al.: Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014; 2(8): 611-620.
10. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med. 2000; 342(18): 1301-1308.
11. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008; 295(3): L379-99.
12. Futier E, Constantin JM, Paugam-Burtz C, et al.: A trial of intraoperative low-tidal-volume ventilation in abdominal surgery. N Engl J Med. 2013; 369(5): 428-437.
13. Ferguson ND, Cook DJ, Guyatt GH, et al.: High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med. 2013; 368(9): 795-805.
14. Young D, Lamb SE, Shah S, et al.: High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med. 2013; 368(9): 806-813.
15. Muscedere JG, Mullen JB, Gan K, et al.: Tidal ventilation at low airway pressures can augment lung injury. Am J Respir Crit Care Med. 1994; 149(5): 1327-1334.
16. Standiford TJ, Ward PA: Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl Res. 2016; 167(1): 183-191.
17. Briel M, Meade M, Mercat A, et al.: Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010; 303(9): 865-873.
18. Han S, Mallampalli RK: The acute respiratory distress syndrome: from mechanism to translation. J Immunol. 2015; 194(3): 855-860.
19. Slutsky AS, Ranieri VM: Ventilator-induced lung injury. N Engl J Med. 2014; 370(10): 979-980.
20. Papazian L, Forel JM, Gacouin A, et al.: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363(12): 1107-1116.
21. Hraiech S, Dizier S, Papazian L: The use of paralytics in patients with acute respiratory distress syndrome. Clin Chest Med. 2014; 35(4): 753-763.
22. Slutsky AS: Neuromuscular blocking agents in ARDS. N Engl J Med. 2010; 363(12): 1176-1180.
23. Forel JM, Roch A, Marin V, et al.: Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006; 34(11): 2749-2757.
24. Fanelli V, Morita Y, Cappello P, et al.: Neuromuscular Blocking Agent Cisatracurium Attenuates Lung Injury by Inhibition of Nicotinic Acetylcholine Receptor-a1. Anesthesiology. 2016; 124(1): 132-140.
25. Benson AB, Albert RK: Prone positioning for acute respiratory distress syndrome. Clin Chest Med. 2014; 35(4): 743-752.
26. Guérin C, Reignier J, Richard JC, et al.: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368(23): 2159-2168.
27. Soo Hoo GW: In prone ventilation, one good turn deserves another. N Engl J Med. 2013; 368(23): 2227-2228.
28. Repessé X, Charron C, Vieillard-Baron A: Acute respiratory distress syndrome: the heart side of the moon. Curr Opin Crit Care. 2016; 22(1): 38-44.
29. Vieillard-Baron A, Charron C, Caille V, et al.: Prone positioning unloads the right ventricle in severe ARDS. Chest. 2007; 132(5): 1440-1446.
30. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, et al.: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006; 354(24): 2564-2575.
31. Grissom CK, Hirshberg EL, Dickerson JB, et al.: Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome*. Crit Care Med. 2015; 43(2): 288-295.
32. Mikkelsen ME, Christie JD, Lanken PN, et al.: The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med. 2012; 185(12): 1307-1315.
33. Silversides JA, Ferguson AJ, McAuley DF, et al.: Fluid strategies and outcomes in patients with acute respiratory distress syndrome, systemic inflammatory response syndrome and sepsis: a protocol for a systematic review and metaanalysis. Syst Rev. 2015; 4: 162.
34. Chen ZL, Song YL, Hu ZY, et al.: An estimation of mechanical stress on alveolar walls during repetitive alveolar reopening and closure. J Appl Physiol (1985). 2015; 119(3): 190-201.
35. Walter J, Ware LB, Matthay MA: Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis. Lancet Respir Med. 2014; 2(12): 1016-1026.
36. Wilson JG, Liu KD, Zhuo H, et al.: Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015; 3(1): 24-32.
37. Festic E, Kor DJ, Gajic O: Prevention of acute respiratory distress syndrome. Curr Opin Crit Care. 2015; 21(1): 82-90.